Intrauterine adhesions, also widely recognized as Asherman syndrome, affect up to 30.4% of women following hysteroscopic adhesiolysis, according to a recent exploratory systematic review cited in clinical evaluations by researchers such as Angelo Hooker, MD, PhD. While 69.6% of patients achieve an adhesion-free uterine cavity after a single surgical intervention, the risk of recurrence remains a major hurdle in treating secondary infertility worldwide.
The Underlying Pathophysiology of Endometrial Injury
Intrauterine adhesions arise primarily from surgical trauma to the basalis layer of the endometrium. Up to 91% of cases stem from pregnancy-related uterine procedures, including surgical management for miscarriages, pregnancy terminations, retained products of conception, or standard deliveries, as documented in clinical literature reviewed by Angelo Hooker, MD, PhD.
The physical disruption of opposing uterine walls triggers a complex cascade of events. Inflammation, altered angiogenesis, abnormal extracellular matrix remodeling, impaired fibrinolysis, and fibrosis combine to obliterate partial or complete segments of the uterine cavity and cervical canal. Constitutional factors, patient nutritional status, local hypoxia, and postoperative infections can exacerbate this scarring process, with the risk of adhesion formation increasing proportionally with the number of surgical procedures a patient undergoes.
Hysteroscopic Adhesiolysis Restores Normal Uterine Anatomy
For patients diagnosed with intrauterine adhesions, hysteroscopically directed adhesiolysis serves as the primary surgical intervention. Direct visualization allows surgeons to assess the location and extent of the scar tissue while selectively dividing it to restore normal uterine anatomy.
Surgeons generally utilize two distinct methods during the procedure:
- Mechanical Dissection: Uses cold scissors without an energy source, which clinical reviews associate with significantly less adhesion reformation.
- Electrosurgical Dissection: Employs monopolar or bipolar radiofrequency instruments.
Despite successful anatomical restoration, the underlying damage to the functional basalis layer remains. Because of this baseline damage, recurrence rates following the primary procedure reach up to 66% across various clinical cohorts.
Postoperative Strategies Fail to Eliminate Adhesion Recurrence
To mitigate the high rate of adhesion recurrence, clinicians apply various postoperative strategies, including mechanical intrauterine barriers, biological barrier agents, and targeted hormonal therapy. However, clinical data indicates that no single preventive method has demonstrated absolute superiority in clinical trials.
Studies evaluated in recent systematic reviews show no statistically significant difference in recurrence rates between patients who receive postoperative antibiotic treatments and those who do not. The persistence of high recurrence rates is attributed to variations in patient populations, baseline scar severity, and surgical techniques utilized during the primary procedure.
What Distinguishes Intrauterine Adhesions from Asherman Syndrome?
What distinguishes intrauterine adhesions from Asherman syndrome?
While clinicians often use the terms interchangeably, the original definition of Asherman syndrome specifically designated pregnancy-related adhesions accompanied by specific clinical symptoms, whereas intrauterine adhesions can occur due to other surgical causes and may sometimes present without symptoms.
Why do adhesions frequently reform after surgery?
Recurrence is driven by the extent of baseline damage to the underlying basalis layer, the presence of inflammation or infection, and the limited availability of local stem cells necessary for proper functional endometrial repair.
How effective is the initial surgical treatment?
A recent exploratory systematic review indicates that 69.6% of women achieve a completely adhesion-free uterine cavity after just one hysteroscopic procedure, leaving a 30.4% recurrence rate.
Related reading